| P50 | author | Khalid Z. Masoodi | Q48235634 |
| | Leandro M Colli | Q56427644 |
| | Laura E Pascal | Q57144929 |
| | Zhou Wang | Q92438654 |
| | Jian Zhang | Q95001421 |
| | Ricardo Zorzetto Nicoliello Vêncio | Q102311386 |
| | Yujuan Wang | Q123574061 |
| P2093 | author name string | Yi Lu | |
| | Yao Wang | |
| | Lora H Rigatti | |
| | Tiejun Yang | |
| | Yachen Zang | |
| | Uma Chandran | |
| | June Liu | |
| | Xiaonan Qiu | |
| | Qiong Song | |
| P2860 | cites work | Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3 | Q22254564 |
| | The little elongation complex regulates small nuclear RNA transcription | Q24300557 |
| | Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia | Q24310726 |
| | Human mediator subunit MED26 functions as a docking site for transcription elongation factors | Q24310867 |
| | EAF2 suppresses hypoxia-induced factor 1α transcriptional activity by disrupting its interaction with coactivator CBP/p300 | Q24319939 |
| | ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL | Q24531614 |
| | The program of androgen-responsive genes in neoplastic prostate epithelium | Q24535711 |
| | Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer | Q24616117 |
| | Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice | Q24647139 |
| | DAVID: Database for Annotation, Visualization, and Integrated Discovery | Q27499374 |
| | ELL2, a new member of an ELL family of RNA polymerase II elongation factors | Q28117345 |
| | Analyzing real-time PCR data by the comparative C(T) method | Q28131831 |
| | ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties | Q28215725 |
| | HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer | Q37484581 |
| | Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer | Q38768101 |
| | The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells | Q40183503 |
| | RTN4-C gene expression in hepatocellular carcinoma and its influence on SMMC7721 cell growth and apoptosis. | Q40366476 |
| | Identification and characterization of a bovine neurite growth inhibitor (bNI-220). | Q42828131 |
| | PDS5A, a novel translocation partner of MLL in acute myeloid leukemia | Q44271844 |
| | The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. | Q46021705 |
| | Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy. | Q54522194 |
| | Angiogenesis and prostate cancer: identification of a molecular progression switch | Q73715181 |
| | SCC-112, a novel cell cycle-regulated molecule, exhibits reduced expression in human renal carcinomas | Q28250311 |
| | The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 |
| | Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 |
| | Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer | Q28587720 |
| | U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia | Q28590029 |
| | Nonredundant roles of the elongation factor MEN in postimplantation development | Q28594021 |
| | The mutational landscape of lethal castration-resistant prostate cancer | Q29614634 |
| | Androgen regulation of spermidine synthase expression in the rat prostate | Q31040745 |
| | Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation | Q32079218 |
| | The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia | Q33493120 |
| | U19/Eaf2 binds to and stabilizes von hippel-lindau protein | Q33590977 |
| | Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53 | Q33604141 |
| | ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells | Q33802059 |
| | AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia | Q33857407 |
| | Cell- and gene-specific regulation of primary target genes by the androgen receptor | Q34005736 |
| | dELL is an essential RNA polymerase II elongation factor with a general role in development | Q34076115 |
| | Transcription elongation factor ELL2 drives Ig secretory-specific mRNA production and the unfolded protein response | Q34364860 |
| | A human protein atlas for normal and cancer tissues based on antibody proteomics | Q34446479 |
| | Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model | Q34740903 |
| | Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice | Q35048524 |
| | Dynamic transcriptional events in embryonic stem cells mediated by the super elongation complex (SEC). | Q35128809 |
| | EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate | Q35161330 |
| | The eleven-nineteen lysine-rich leukemia gene (ELL2) influences the histone H3 protein modifications accompanying the shift to secretory immunoglobulin heavy chain mRNA production | Q35310763 |
| | Regulation of fertility, survival, and cuticle collagen function by the Caenorhabditis elegans eaf-1 and ell-1 genes | Q35372544 |
| | Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats | Q35468651 |
| | Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. | Q35693712 |
| | Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy | Q35976992 |
| | RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect | Q36026989 |
| | Physical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion. | Q36272250 |
| | Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation | Q36700425 |
| | Bleach gel: a simple agarose gel for analyzing RNA quality | Q36975439 |
| | Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate. | Q37373807 |
| | Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing. | Q37408113 |
| | Steroidogenic factor 1 promotes aggressive growth of castration-resistant prostate cancer cells by stimulating steroid synthesis and cell proliferation | Q37479334 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 123-136 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Journal of Endocrinology | Q6295150 |
| P1476 | title | Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia | |
| P478 | volume | 235 | |